The California trial against Monsanto by Dewayne Johnson, a 46-year-old former school groundskeeper, who was diagnosed with non-Hodgkin lymphoma four years ago and claims that Monsanto hid evidence that the active ingredient in its Roundup herbicide, glyphosate, caused his cancer, is nearing the end, where a jury will decide on a verdict. One of the attorneys of the Plaintiff, Robert F. Kennedy, Jr., has been giving updates that are being posted on the Organic Consumers Association website. In a recent update, Mr. Kennedy reported on some of the actions of Judge Bolanos that seemed to suggest that the judge could be potentially biased in favor of Monsanto by not allowing some key evidence, some of which seems to contradict what another judge, Judge Curtis Karnow, seemed to rule was admissible in pre-trial hearings. In spite of these limitations, Mr. Kennedy feels that the trial is going their way as it is finishing up and being delivered to the jury.
Exposure to environmentally relevant doses of a glyphosate-based herbicide during pregnancy has been found not only to impair female fertility in rats, but to induce foetal growth retardation and malformations, including abnormally developed limbs, in their second-generation offspring. Argentinian researchers tested the glyphosate-based herbicide – one commonly used in Argentina – in pregnant female rats at two doses, which were added to their food. The rats were mated and dosed from the 9th day after conception until their pups were weaned. This first generation of offspring and their offspring in turn (second generation) were followed and monitored for reproductive effects. The lower dose of glyphosate tested, 2 mg/kg bw/day (2 mg per kg of bodyweight per day), was in the order of magnitude of the reference dose (RfD) of 1 mg/kg bw/day recently set for glyphosate by the US Environmental Protection Agency, based on industry's developmental toxicity studies. The "reference dose" is the dose that is supposed to be safe to ingest on a daily basis over a lifetime. The authors added that this dose is representative of the glyphosate residues found in soybean grains and is in the order of magnitude of the environmental levels detected in Argentina. The higher dose of glyphosate, 200 mg of glyphosate/kg bw/day, was selected based on the industry-declared no-observed adverse effect level (NOAEL) of 1000 mg/kg bw/day for maternal toxicity established in rats. In other words, according to industry's own tests, this dose should not have been toxic to the mothers and thus should not have harmed the foetuses. But harmful effects did occur.
Hundreds of lawsuits against Monsanto Co by cancer survivors or families of those who died can proceed to trial, a federal judge ruled on Tuesday, finding there was sufficient evidence for a jury to hear the cases that blame the company's glyphosate-containing weed-killer for the disease. The decision by U.S. District Judge Vince Chhabria in San Francisco followed years of litigation and weeks of hearings about the controversial science surrounding the safety of the chemical glyphosate, the key ingredient in Monsanto's top-selling weed-killer.
A California Superior Court ruled last week that a man dying of cancer, who is suing Monsanto, can present evidence that Monsanto covered up research linking glyphosate to cancer. Glyphosate is the main ingredient in Roundup, the world's most prevalent herbicide used in agriculture, that has been found in 93% of Americans' urine, most mothers' breast milk, and is probably residing inside of every person alive on planet Earth. Provided that the trial will go forward without any more legal maneuvering by Monsanto, 46-year-old DeWayne Johnson, who has terminal cancer and only months left to live, will take the stand against Monsanto in a California court on June 18, in what is being called a "Landmark Lawsuit." Last week Judge Curtis Karnow issued an order clearing the way for jurors to consider not just scientific evidence related to what caused Johnson’s cancer, but allegations that Monsanto suppressed evidence of the risks of its weed killing products. Karnow ruled that the trial will proceed and a jury would be allowed to consider possible punitive damages. There are more than 4,000 other cancer victims who have filed lawsuits against Monsanto since the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) published a report linking glyphosate to non-Hodgkin lymphoma back in 2015. Therefore, should this case actually make it to trial, and DeWayne Johnson gets his day in court before a jury, it could set quite a precedent.
Glyphosate-based herbicide caused adverse health effects in rats at a dose claimed to be safe by regulators, according to a new study. Glyphosate herbicides are used on the vast majority of all GM crops worldwide. The study used the US Environmental Protection Agency’s acceptable daily dietary exposure level of glyphosate – 1.75 mg per kg of bodyweight per day. The same concentration was given to the rats daily over a 3-month period. The study was focused on the newborn, infancy and adolescence phases of life. The results reveal that glyphosate-based herbicide (GBH) was able to alter certain important biological parameters, mainly relating to sexual development, genotoxicity, and the intestinal microbiome. The effects occurred at a dose deemed safe by regulators to ingest on a daily basis over a long-term period. In human-equivalent terms the dosing period corresponded to the period from the embryo stage to 18 years of age.
People living in an Argentine town in the heart of the GM soy and maize growing area suffer miscarriages at three times and birth defects at twice the national average rate, a new study shows. In addition, the study found a correlation between a high environmental exposure to glyphosate and an increased frequency of reproductive disorders (miscarriage and birth defects).
The Environmental Protection Agency is seeking public input on the health impacts of glyphosate, the active ingredient in Monsanto’s Roundup herbicide. But despite mounting evidence, the EPA continues to ignore glyphosate’s hazards, and it looks like Monsanto’s under-the-table influence may be a reason why. Monsanto has launched a campaign to pressure the EPA into declaring glyphosate safe. It is terrified of losing the profits from selling this ubiquitous herbicide. The use of glyphosate on U.S. farmland has exploded in recent years. A recent study found that Americans’ exposure to the pesticide has increased fivefold since it was first introduced more than 20 years ago.
A federal judge in San Francisco will hear from expert witnesses on the science and safety of glyphosate at critical hearing starting Monday that will determine if plaintiffs around the country can move forward with their legal action against Monsanto over cancer claims. More than 365 pending lawsuits against the agribusiness giant have been centralized in multidistrict litigation under U.S. District Judge Vince Chhabria. The plaintiffs claim they or their loved ones developed non-Hodgkin Lymphoma (NHL) due to exposure to glyphosate, the active ingredient in Monsanto's Roundup weedkiller. During the week-long hearing—dubbed "Science Week"—epidemiologists, oncologists, toxicologists and other scientists representing both sides will offer testimony about glyphosate. The judge will not decide whether or not glyphosate causes cancer. Rather, Chhabria will determine if the experts providing scientific opinions regarding causation will be permitted to testify at trial, explained Baum, Hedlund, Aristei & Goldman, one of the law firms leading the litigation.
The story with Monsanto’s round that begins as early as the 1980s when laboratory tests on glyphosate began to show cellular changes in laboratory animals that should’ve been considered early signals of a relationship clearly to cancer. In fact, in 1985 the EPA determined that glyphosate, which is the primary ingredient in Roundup, needed to be classified as a Class C carcinogen, which meant that it clearly is suggested of a relationship to cancer. But then miraculously for some reason six years later the EPA suddenly changed that classification to something just the opposite. Now they were saying that they were wrong to classify it as a possible carcinogen and that the public had nothing to worry about when using products that contained this chemical. That was their change. Then all of a sudden the laboratory data from the early ’80s that the EPA use to classify glyphosate as cancer suddenly became unavailable to the public. Why? Because Monsanto argued that all the early testing results for this chemical fell under a protection of trade’s secret rule, meaning they didn’t have to share this information with the general public. It was theirs. They were going to keep it quiet. Joining me now to talk about this is Carey Gillam, author of the book Whitewash: The Story of Weed Killer, Cancer, and Corruption of Science.
No-Till Farmer is a magazine aimed at farmers who grow GM glyphosate-tolerant corn and soybeans using herbicides instead of ploughing to control weeds. In a revealing sign of the times, the magazine has published an article detailing the serious problems of soil and plant health caused by the application of glyphosate on these GM crops in no-till systems. The paywalled article, written by No-Till Farmer's senior editor John Dobberstein, draws on the expertise of Robert Kremer, a retired research microbiologist with the USDA-Agricultural Research Service and adjunct professor at the University of Missouri, as well as other researchers. Noting that "there may be trouble on the horizon for glyphosate," Dobberstein says that when measured by pounds applied per square mile, the use of glyphosate has increased from less than 1 million pounds in 1974 to 28 million pounds in 1995, and 80 million pounds in 2010. Between 1974 and 2014, 30 billion pounds of glyphosate were applied to US agricultural lands, according to federal data.